World first: breast cancer drug helps lung cancer patient
When an advanced lung cancer patient passed out from acute hypoglycemia, doctors tried a treatment that proved a successful scientific breakthrough.
When an advanced lung cancer patient passed out from acute hypoglycemia, doctors tried a treatment that proved a successful scientific breakthrough.
Abu Lawi, who lives in Qatar, chose Israel’s Assuta Medical Center for his cancer treatment.
Groundbreaking therapy — involving a laser and the novel drug, TOOKAD Soluble – kills cancerous tumor tissue without harming the patient.
Quiet Therapeutics’ specially coated nanoparticles act like Trojan Horses entering cancer cells undetected and then killing them.
A first-in-class pocket-sized metered-dose cannabis inhaler helps patients and doctors control, monitor and fine-tune dosages.
Hebrew University’s tech-transfer company, Yissum, partners with the likes of J&J, P&G, Merck, Roche, Novartis, Microsoft, Intel, Coca-Cola and Monsanto.
Possible new treatment approach suggested by Arab-Israeli pediatrician’s discovery of how interrupted sleep speeds the spread of cancer.
For the first time, there is hope of natural conception for young female cancer patients undergoing cancer treatment.
Israel’s RedHill Biopharma plans an advanced clinical trial for a once-a-day drug to prevent nausea and vomiting following cancer therapy.
An Israeli-developed biodegradable ‘balloon’ separates tumors from healthy tissues, greatly reducing side effects of radiation therapy in prostrate cancer.
In an impressive year for Israeli science, ISRAEL21c reviews some of its most popular stories of the year, from breakthroughs in cancer, to mind-controlled computing and solar windows.